AMPHASTAR PHARMACEUTICALS IN - NOTE 2.000% 3/1

Historical Holders from Q3 2024 to Q1 2025

CUSIP
03209RAB9
Type / Class
Debt / NOTE 2.000% 3/1
All holders as of December 31, 2024
Q4 2024
Principal, excl. options
310M
Holdings value
$291M
% of all portfolios
0.002%
Grand Portfolio weight change
0%
Number of holders
36
Number of buys
17
Number of sells
-21
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of AMPHASTAR PHARMACEUTICALS IN - NOTE 2.000% 3/1

Period Principal Value Change Price Investors
2025 Q1 $11K $9.76K -$382K $0.89 1
2024 Q4 $310M $291M -$11.3M $0.93 36
2024 Q3 $320M $339M +$336M $1.06 35